DJIA 17,777.98 94.40 0.53%
NASDAQ 4,998.19 6.25 0.13%
S&P 500 2,079.15 10.39 0.50%
market minute promo

Abbott Laboratories (NYSE: ABT)

50.17 0.43 (0.85%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ABT $50.20 0.92%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $49.96
Previous Close $49.74
Daily Range $49.10 - $50.21
52-Week Range $39.28 - $50.47
Market Cap $74.7B
P/E Ratio 37.40
Dividend (Yield) $0.96 (1.9%)
Ex-Dividend Date
Dividend Pay Date
Volume 4,597,663
Average Daily Volume 4,888,126
Current FY EPS $2.16




Drug Makers

Abbott Laboratories (ABT) Description

Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. Website:

News & Commentary Rss Feed

Better Dividend Stock: AbbVie or Johnson & Johnson?

AbbVie and Johnson & Johnson are widely recognized as top-tier dividend stocks. Here is a look at which one offers the better long-term prospects for income-seeking investors.

Benzinga's M&A Chatter for Monday July 6, 2015

Aeterna Zentaris' Endometrial Cancer Study Fully Enrolled - Analyst Blog

The Best Way To Judge Past Performance: Part 2

Intercept Pharmaceuticals Files for OCA in U.S. and Europe - Analyst Blog

Intercept Pharmaceuticals Files for OCA in U.S. and Europe - Analyst Blog

Roche's Multiple Sclerosis Studies Meet Primary Endpoint - Analyst Blog

Novartis' Cosentyx Positive in Psoriatic Arthritis Study - Analyst Blog

Roche's Perjeta Recommended for Pre-Surgery Breast Cancer - Analyst Blog

Noteworthy ETF Outflows: JKD, ABBV, USB, ABT

Investors Need A Retirement Strategy For All Seasons

See More ABT News...

ABT's Top Competitors

ABT $50.17 (0.85%)
Current stock: ABT
JNJ $98.87 (0.68%)
Current stock: JNJ
NVS $99.06 (0.45%)
Current stock: NVS
RHHBY $35.00 (-0.27%)
Current stock: RHHBY